Modulation by adrenergic transmitters of the efferent function of capsaicin-sensitive nerves in cardiac tissue

Neuropeptides. 1991 Dec;20(4):225-32. doi: 10.1016/0143-4179(91)90012-8.

Abstract

In atrial preparations obtained from reserpine-pre-treated guinea-pigs, incubated in the presence of 1 microM atropine plus 1 microM CGP 20712A (a beta 1 blocking drug), a positive inotropic effect due to CGRP release from capsaicin-sensitive sensory neurons was induced by electrical field stimulation (EFS). This response was concentration-dependently reduced by noradrenaline (0.01-3 microM), neuropeptide Y (NPY, 3-300 nM) and adenosine triphosphate (ATP, 1-30 microM). On the other hand, the overflow of [3H]-noradrenaline from sympathetic nerve terminals induced by EFS in isolated atria obtained from normal untreated animals was not modified in 10 nM calcitonin gene-related peptide (CGRP). Substance P (SP) and neurokinin A (NKA), at concentrations ranging from 0.01 to 1 microM did not affect the cardiac response to field stimulation of adrenergic terminals of atrial tissue. These findings demonstrate that all the co-transmitters stored in adrenergic nerve terminals have a modulatory role on the efferent function of cardiac capsaicin-sensitive sensory neurons, while cardiac adrenergic neurotransmission is not influenced by the peptidergic transmitters released from sensory neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Adrenergic beta-Antagonists / pharmacology*
  • Animals
  • Atropine / pharmacology*
  • Calcitonin Gene-Related Peptide / pharmacology
  • Capsaicin / pharmacology*
  • Electric Stimulation
  • Guinea Pigs
  • Heart Atria
  • Heart Conduction System / drug effects*
  • Imidazoles / pharmacology*
  • In Vitro Techniques
  • Male
  • Myocardial Contraction / drug effects*
  • Neurokinin A / pharmacology
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / physiology*
  • Neuropeptide Y / pharmacology
  • Norepinephrine / metabolism
  • Norepinephrine / pharmacology*
  • Phenoxybenzamine / pharmacology
  • Substance P / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Imidazoles
  • Neuropeptide Y
  • Phenoxybenzamine
  • Substance P
  • Atropine
  • Neurokinin A
  • Adenosine Triphosphate
  • CGP 20712A
  • Calcitonin Gene-Related Peptide
  • Capsaicin
  • Norepinephrine